683 Capital Management »

Benitec Biopharma shares owned by 683 Capital Management

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $452k 36k 12.63

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
BlackRock
Nantahala Capital Management
Infinitum Asset Management
Geode Capital Management
Silverarc Capital Management
Schonfeld Strategic Advisors
State Street Corporation
Goldman Sachs Group
AWM Investment Company
Ameriprise Financial

View all funds holding Benitec Biopharma